INTRODUCTION
Thalassemia as the most common genetic disorder worldwide is regarded as a serious problem in public health issues in the Mediterranean region, Southeast Asia, the Indian subcontinent and the Middle East, including Iran. 1, 2 Iran is located on the thalassemia belt in the world and thalassemia carriers are evaluated from 1 to 10 percent [average % 4.5] transitively. 3 According to the statistics, the number of patients with thalassemia major (the most severe form of thalassemia) in Iran is more than 20,000 individuals. 4 Thalassemia affects the synthesis of globin chain and according to the number and type of the involved chains, clinical symptoms vary. Betathalassemia is the most common frequent type of thalassemia which presents in three forms: thalassemia minor which leads to a mild asymptomatic haemolytic anaemia, thalassemia intermediate and major.
Interestingly, thalassemia major is the most severe form of beta-thalassemia leading to severe anaemia and patients are in need of blood transfusion since the young age; this type may end in heart failure , due to iron overload, or early death in childhood in case of no transfusion. 5 Nowadays, with improvements in the treatment of patients with thalassemia, these patients have a longer life expectancies and a larger number of them reach older ages. 6 As a result of this increase in life expectancy, their needs also change and entities such as continuing education, career and family making become more prominent amongst them. 7 It is then anticipated that effective and suitable life background would be prepared for them in the society and they become as active as other members of the society. 8 An increase in the life expectancy is accompanied by certain challenges such as bone diseases, infertility, consecutive referrals for blood transfusion, subcutaneous infusion of chelators, and moral stresses, which these aforementioned problems would affect mental, physical, social and educational functions of these patients. 1, 7 Hence, authorities who provide services to patients should be aware of the related mental and social consequences in addition to the burden of this disease, just like any other chronic disease, to prepare better living environment for these patients. 8 Therefore, in this study, we aimed to measure the Quality of life in patients with beta-thalassemia major using SF-36 for the first time in who referred to Thalassemia Clinic of BU-Ali Hospital in Ardabil, Iran.
METHODS
This is a cross-sectional study that has been done on patients (aged ≥ 2 years) with major beta-thalassemia of both genders attending the Haematology & Oncology Center of Bu-Ali Hospital in Ardabil province, located on the North West of Iran. Data were collected between December 2013 and May 2014. The total sample was 43. No sample size calculations were carried out prior to the study. We assessed Thalassemia Major Patients who were dependent on blood transfusions, and who visited for monthly blood transfusions and clinical examinations. Thalassemia major diagnosis was based on the results of electrophoresis of blood haemoglobin. The study protocol was approved by both the Institutional Review Board and the Ethics Committee of Ardabil University of Medical Science. Informed written consent was obtained from all patients. For data collection, questionnaires were used. The researcher-made demographic questionnaire included age, gender, educational level employment status, marital status. The Persian version of the SF-36 questionnaire was used in this study, and this had previously been translated from English and validated (9) .This questionnaire evaluated the general health of thalassemia major patients according to 8 categories: physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role-emotional (RE) and mental health (MH). The Cronbach alpha for the reliability of this questionnaire has been found to range from 0.77 to 0.90 in Iran and from 0.65 to 0.96 in other countries. 10 The total score of these 8 indices ranged between 0 and 100, with designations of weak (≤20), bad (21-40), good (41-60), very good (61-80), and excellent (>81). 10 Questionnaires were written through interviews and completed by trained students. Explanations about the disease and reasons for conducting this study were given to the patients, and permission to complete the questionnaire was obtained from the patient and parents. Literate patients were asked to complete the questionnaire themselves if they wished. Those who were illiterate were assisted by a trained researcher. Considering the young age of the patients, questions were asked, and interviews were conducted in such a way so as not to undermine integrity and independence of questions. Data was analysed using descriptive statistics (frequency, mean, and standard deviation) and inferential statistics (t-test) in SPSS-16 software. P-value of less than 0.05 was considered statistically significant. (Figure 1 ). Unlike income, there wasn't any significant relationship between age and the quality of life scores (p>0.005). 
RESULTS

DISCUSSION
Thalassemia Major has become a major general health problem throughout the world, especially in developing and poor countries. 9 Thalassemia major is usually recognized in childhood, at which time patients begin treatment. Over their lives, however, patients and their families are at risk for social and behavioural disorders. Due to distress from both the illness itself and the need for iron chelation, thalassemia subjects frequently display maladaptive coping strategies and high levels of anxiety with psychosocial dysfunction. 10 The quality of life amongst the patients with thalassemia in Ardabil is very good in eight domains under study except general health compared to the rest of Iranian healthy members (Table  2 ). Such a difference is not surprising since due to special physical conditions and problems related to their disease, patients are not anticipated to have a very good quality of life. 8 The results of a study conducted by Safizadeh et al, on the quality of life among patients affected with thalassemia major aged sixteen years and older, in Kerman city revealed that they had a good quality of life in all domains, as in his study the highest score was seen in PF and SF, and the lowest score in BP and MH. 11 Another study conducted by AzarKeivan on the quality of life among patients affected with thalassemia (major and intermediate) aged eighteen years and older, in Tehran city revealed that they had a very good quality of life in all domains except for MH and BP compared to this present study, in her study the highest score was seen in PF and SF, and the lowest score in BP and MH. 12 In a recent report by Hadi et al, it was reported that in Shiraz has demonstrated a better quality of life in all domains compared to this study, the highest score was seen in RP and Pf and the lowest score in GH and V. 13 The only common point between these three studies and the present study was in PF domain which was better than the other domains; hence it seems that receiving suitable treatments would decrease the patients' physical problems. 19 In our study, higher income was a significant determinant of higher quality of life scores for the physical and mental health dimensions, as well as higher total scores. This was concordant with the results from Tajvar et al. 20 In a study on an elderly Iranian population. Obviously, with better economic status, different populations and especially thalassemia patients would be able to confront their disease-related problems more easily. Among the population studied, 55.8% were not more than 22 years old. We did not find any significant correlation between age and the quality of life scores. Sobotaet al Investigated quality of life in a longitudinal thalassemia cohort aged over 14 years, compared with the norms in the United States, along with the influence of clinical factors. 21 Differing from our results, they showed worse quality of life among older patients. The results have also demonstrated that sex is influential in GH domain and the girls' status seemed to be better. Although it sounds that problems resulting from thalassemia and its treatment are not any different between girls and boys, the expectations from the males in the society (such as managing a family, income, etc.) in Iran can justify these differences. In a study by Hadi, women had a better quality of life in SF domain whereas studies conducted in Thailand and Malaysia has shown that sex is not effective on the quality of life domains. 1, 13, 14 
CONCLUSION
All patients with thalassemia should undergo assessment of quality of life amongst so that interventions focusing on the affected domains can be implemented. In addition, patients with thalassemia and their families often require support in many aspects, especially psychological support to prevent mental disorders.
